Nesbuvir

DB07238InvestigationalSmall molecule

Nesbuvir has been investigated for the treatment of Hepatitis C.

Mechanism: Pharmacologically active on RNA-directed RNA polymerase
Curator reviewed
Formula / weight: C₂₂H₂₃FN₂O₅S · 446.492 g/mol (avg)
Code names: HCV-796

Resolves to

Compound

Structure

InChIKeyWTDWVLJJJOTABN-UHFFFAOYSA-NSMILESCNC(=O)C1=C(OC2=CC(N(CCO)S(C)(=O)=O)=C(C=C12)C1CC1)C1=CC=C(F)C=C1

Targets

What you can answer from here — as of June 15, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Nesbuvir, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.